173 related articles for article (PubMed ID: 26714714)
1. Modeling HIV-1 Mucosal Transmission and Prevention in Humanized Mice.
Veselinovic M; Charlins P; Akkina R
Methods Mol Biol; 2016; 1354():203-20. PubMed ID: 26714714
[TBL] [Abstract][Full Text] [Related]
2. Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice.
Denton PW; Estes JD; Sun Z; Othieno FA; Wei BL; Wege AK; Powell DA; Payne D; Haase AT; Garcia JV
PLoS Med; 2008 Jan; 5(1):e16. PubMed ID: 18198941
[TBL] [Abstract][Full Text] [Related]
3. Mucosal transmission of R5 and X4 tropic HIV-1 via vaginal and rectal routes in humanized Rag2-/- gammac -/- (RAG-hu) mice.
Berges BK; Akkina SR; Folkvord JM; Connick E; Akkina R
Virology; 2008 Apr; 373(2):342-51. PubMed ID: 18207484
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-gamma c-/- (RAG-hu) mouse model.
Berges BK; Wheat WH; Palmer BE; Connick E; Akkina R
Retrovirology; 2006 Nov; 3():76. PubMed ID: 17078891
[TBL] [Abstract][Full Text] [Related]
5. HIV pre-exposure prophylaxis: mucosal tissue drug distribution of RT inhibitor Tenofovir and entry inhibitor Maraviroc in a humanized mouse model.
Veselinovic M; Yang KH; LeCureux J; Sykes C; Remling-Mulder L; Kashuba ADM; Akkina R
Virology; 2014 Sep; 464-465():253-263. PubMed ID: 25105490
[TBL] [Abstract][Full Text] [Related]
6. Mucosal tissue pharmacokinetics of the integrase inhibitor raltegravir in a humanized mouse model: Implications for HIV pre-exposure prophylaxis.
Veselinovic M; Yang KH; Sykes C; Remling-Mulder L; Kashuba AD; Akkina R
Virology; 2016 Feb; 489():173-8. PubMed ID: 26771889
[TBL] [Abstract][Full Text] [Related]
7. HIV Replication and Latency in a Humanized NSG Mouse Model during Suppressive Oral Combinational Antiretroviral Therapy.
Satheesan S; Li H; Burnett JC; Takahashi M; Li S; Wu SX; Synold TW; Rossi JJ; Zhou J
J Virol; 2018 Apr; 92(7):. PubMed ID: 29343582
[TBL] [Abstract][Full Text] [Related]
8. New generation humanized mice for virus research: comparative aspects and future prospects.
Akkina R
Virology; 2013 Jan; 435(1):14-28. PubMed ID: 23217612
[TBL] [Abstract][Full Text] [Related]
9. Immune reconstitution of the female reproductive tract of humanized BLT mice and their susceptibility to human immunodeficiency virus infection.
Olesen R; Wahl A; Denton PW; Garcia JV
J Reprod Immunol; 2011 Mar; 88(2):195-203. PubMed ID: 21256601
[TBL] [Abstract][Full Text] [Related]
10. Characterization of HIV-1 infection in the humanized Rag2-/-γc-/- mouse model.
Sanchez FM; Berges BK
Methods Mol Biol; 2013; 1031():215-22. PubMed ID: 23824904
[TBL] [Abstract][Full Text] [Related]
11. Humanized Mice Engrafted With Human HSC Only or HSC and Thymus Support Comparable HIV-1 Replication, Immunopathology, and Responses to ART and Immune Therapy.
Cheng L; Ma J; Li G; Su L
Front Immunol; 2018; 9():817. PubMed ID: 29725337
[TBL] [Abstract][Full Text] [Related]
12. Mucosal HIV-1 transmission and prevention strategies in BLT humanized mice.
Denton PW; Garcia JV
Trends Microbiol; 2012 Jun; 20(6):268-74. PubMed ID: 22503637
[TBL] [Abstract][Full Text] [Related]
13. Role of Semen on Vaginal HIV-1 Transmission and Maraviroc Protection.
Council OD; Swanson MD; Spagnuolo RA; Wahl A; Garcia JV
Antimicrob Agents Chemother; 2015 Dec; 59(12):7847-51. PubMed ID: 26392489
[TBL] [Abstract][Full Text] [Related]
14. BLT humanized mice as a small animal model of HIV infection.
Karpel ME; Boutwell CL; Allen TM
Curr Opin Virol; 2015 Aug; 13():75-80. PubMed ID: 26083316
[TBL] [Abstract][Full Text] [Related]
15. A long-acting formulation of the integrase inhibitor raltegravir protects humanized BLT mice from repeated high-dose vaginal HIV challenges.
Kovarova M; Swanson MD; Sanchez RI; Baker CE; Steve J; Spagnuolo RA; Howell BJ; Hazuda DJ; Garcia JV
J Antimicrob Chemother; 2016 Jun; 71(6):1586-96. PubMed ID: 27002074
[TBL] [Abstract][Full Text] [Related]
16. Animal models of antiretroviral prophylaxis for HIV prevention.
García-Lerma JG; Heneine W
Curr Opin HIV AIDS; 2012 Nov; 7(6):505-13. PubMed ID: 22964889
[TBL] [Abstract][Full Text] [Related]
17. A humanized mouse model for HIV-2 infection and efficacy testing of a single-pill triple-drug combination anti-retroviral therapy.
Hu S; Neff CP; Kumar DM; Habu Y; Akkina SR; Seki T; Akkina R
Virology; 2017 Jan; 501():115-118. PubMed ID: 27912079
[TBL] [Abstract][Full Text] [Related]
18. Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells.
Lapenta C; Santini SM; Proietti E; Rizza P; Logozzi M; Spada M; Parlato S; Fais S; Pitha PM; Belardelli F
Virology; 1999 Oct; 263(1):78-88. PubMed ID: 10544084
[TBL] [Abstract][Full Text] [Related]
19. Oral pre-exposure prophylaxis by anti-retrovirals raltegravir and maraviroc protects against HIV-1 vaginal transmission in a humanized mouse model.
Neff CP; Ndolo T; Tandon A; Habu Y; Akkina R
PLoS One; 2010 Dec; 5(12):e15257. PubMed ID: 21203568
[TBL] [Abstract][Full Text] [Related]
20. Use of pediatric thymus to humanize mice for HIV-1 mucosal transmission.
Roy CN; Shu ST; Kline C; Rigatti L; Smithgall TE; Ambrose Z
Sci Rep; 2023 Oct; 13(1):17067. PubMed ID: 37816950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
